SpyGlass Pharma discloses FY2025 performance cash bonuses for named executive officers

SpyGlass Pharma, Inc.

Compensation Committee approved FY2025 bonuses on Feb 12, 2026.
CEO Patrick Mooney: $215,088 bonus; total compensation $3,322,711.
President/CMO Malik Y. Kahook: $125,975 bonus; total $2,484,469.
Chief R&D Officer Chetan Pujara: $126,289 bonus; total $1,539,952.
Bonuses previously undisclosed in S-1; updated comp table filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.